Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial
Ashley Verburg*, Wilbert L. Bor, I. Tarik Küçük, José P.S. Henriques, Maarten A. Vink, Willem Peter T. Ruifrok, Jacobus Plomp, Ton A.C.M. Heestermans, Carl E. Schotborgh, Pieter J. Vlaar, Michael Magro, Sem A.O.F. Rikken, Wout W.A. van den Broek, Carlos A.G. van Mieghem, Kristoff Cornelis, Liesbeth Rosseel, Karl S. Dujardin, Bert Vandeloo, Tom Vandendriessche, Bert FerdinandeArnoud W.J. van’t Hof, Jan G.P. Tijssen, Ugo Limbruno, Raffaele De Caterina, Andrea Rubboli, Dominick J. Angiolillo, Tom Adriaenssens, Willem Dewilde, Jurrien M. ten Berg
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Temporary omission of oral anticoagulation in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and design of the WOEST-3 randomised trial'. Together they form a unique fingerprint.